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The study of poxvirus entry and membrane fusion has been invigorated by new biochemical and microscopic findings that lead to the
following conclusions: (1) the surface of the mature virion (MV), whether isolated from an infected cell or by disruption of the membrane wrapper
of an extracellular virion, is comprised of a single lipid membrane embedded with non-glycosylated viral proteins; (2) the MV membrane fuses
with the cell membrane, allowing the core to enter the cytoplasm and initiate gene expression; (3) fusion is mediated by a newly recognized group
of viral protein components of the MV membrane, which are conserved in all members of the poxvirus family; (4) the latter MV entry/fusion
proteins are required for cell to cell spread necessitating the disruption of the membrane wrapper of extracellular virions prior to fusion; and
furthermore (5) the same group of MV entry/fusion proteins are required for virus-induced cell–cell fusion. Future research priorities include
delineation of the roles of individual entry/fusion proteins and identification of cell receptors.
Published by Elsevier Inc.
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Poxviruses constitute a large family of enveloped DNA
viruses that replicate entirely in the cytoplasm of infected
vertebrate or invertebrate cells (Moss, 2001). In a recent
tabulation of viral membrane fusion proteins (Earp et al.,
2005), poxviruses and the distantly related iridoviruses had the
dubious distinction of being the only virus families with the
entry ‘‘Not Determined.’’ Poxviruses also did not make a list of0042-6822/$ - see front matter. Published by Elsevier Inc.
doi:10.1016/j.virol.2005.09.037
E-mail address: bmoss@nih.gov.viruses with known cell receptors (Sieczkarski and Whittaker,
2005). Happily, progress in understanding poxvirus entry has
accelerated, and recent biochemical and microscopic discover-
ies are bringing order and direction to the field. Readers of this
review may wish to consult an article on the formation and
function of extracellular virions (Smith et al., 2002).
Mature virions
Investigations of the mechanism(s) used by vaccinia virus
(VACV), the prototype poxvirus, to enter cells have been
complicated by the existence of multiple infectious forms that06) 48 – 54
www.e
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Nevertheless, each form contains the same DNA–protein
core, with numerous enzymes and factors for early gene
expression, that is surrounded by a lipid membrane with more
than a dozen viral proteins, none of which are glycosylated
(Moss, 2001). The ‘‘simplest’’ and most abundant form has no
additional membranes and is referred to here as a mature
virion (MV), although it has previously been called the
intracellular mature virion. Until recently, it was accepted that
the MV membrane is comprised of a single lipid bilayer. This
view was based on electron micrographs published by Dales
and Mosbach (1968) and other investigators over many years.
Griffiths et al. (2001a, b), however, proposed an alternative
model in which the surface of the MV consists of two closely
apposed membrane bilayers. The latter model originated with
the plausible idea that the immature viral membrane forms
from a flattened cisterna derived from a cellular organelle
(Sodeik et al., 1993). Nevertheless, only a single membrane
bilayer has been resolved even with modern transmission
electron microscopic methods (Hollinshead et al., 1999) and
the latest cryo-electron tomography techniques (Cyrklaff et
al., 2005). Moreover, freeze fracture studies provide no
evidence for more than a single bilayer (Heuser, 2005).
Therefore, although the two-membrane model is appealing
with regard to the genesis of the viral membrane, current data
support the existence of a single membrane at the surface of
the MV. Moreover, the presence of a single membrane is
consistent with a fusion mode of entry for which there is
considerable evidence.
MVs purified from infected cells by sucrose gradient
sedimentation are most often used for entry experiments.
However, it should be recognized that some MVs may be
damaged or not completely mature, perhaps accounting in part
for the relatively high (¨50) ratio of particles to plaque
forming units. Ichihashi and colleagues (Ichihashi and Oie,
1980, 1982; Oie et al., 1990, Ichihashi, 1996) reported that the
majority of MVs isolated at late times after infection are in a
‘‘protected’’ state and must be activated by proteolysis in order
to penetrate cells efficiently.Fig. 1. Transmission electron micrographs of the MV (left panel), WV (middle pane
membrane of MV. Middle panel: one arrow points to the MV membrane and two
wrapping membrane that has fused with the plasma membrane and the others to the
kindly provided by Andrea S. Weisberg.Extracellular virions
The MV may undergo additional membrane wrapping by a
trans-Golgi (Hiller and Weber, 1985; Schmelz et al., 1994) or
endosomal (Tooze et al., 1993) cisterna that has been modified
by the insertion of at least seven viral proteins (Smith et al.,
2002). The usual name of this form, which has two membranes
surrounding the MV, is ‘‘intracellular enveloped virion.’’
However, the descriptive name wrapped virion (WV) will be
used here to eliminate possible confusion as the MV already
has a membrane envelope (Fig. 1). The WV moves along
microtubules to the periphery of the cell (Moss and Ward,
2001; Smith et al., 2002). Upon reaching the plasma
membrane, the outer WV membrane fuses with the plasma
membrane resulting in exocytosis. Extracellular virions (EVs)
may be divided into cell-associated (Fig. 1) and unattached
forms of which the former is usually predominant (see next
paragraph) and chiefly responsible for cell-to-cell spread with
the aid of actin tails (Blasco and Moss, 1992; Roper et al.,
1998; Sanderson et al., 1998; Wolffe et al., 1997; Wolffe et al.,
1998). The EV can be thought of as consisting of an MV
surrounded by one additional membrane wrapper, though there
are differences between an MV released by lysis of cells and
disruption of the EV wrapper (Ichihashi and Oie, 1982; Ulaeto
et al., 1996) which may in part account for the enhanced ability
of EV to penetrate and fuse with cells (Doms et al., 1990;
Ichihashi, 1996; Payne and Norrby, 1978). The EV wrapper
contains at least four glycoproteins and one non-glycosylated
protein, none of which are present in the enclosed MV
membrane. The fragility of the EV wrapper can cause problems
in the study of EV entry as particles with broken membranes
are present even in fresh medium and their numbers increase
after freeze and thaw or purification (Ichihashi, 1996).
In the case of the commonly used Western Reserve (WR)
strain of VACV, the predominant form of EV remains cell-
associated even at late times after infection (Blasco and Moss,
1992). The unattached form of EV (i.e. the form released into
the culture medium) constitutes only about 0.5% of the total
infectious WR strain of VACV (Payne, 1979). In contrast, thel), and EV (right panel) forms of VACV. Left panel: arrow points to the single
to the outer wrapping membranes. Right panel: one arrow points to the outer
MV membrane and remaining EV wrapper. Electron microscopic images were
B. Moss / Virology 344 (2006) 48–5450unattached EV constitutes from 8 to 27% of the total IHD-J
strain, depending on the cell type (Payne, 1979). Marker rescue
studies showed that the dissimilarity in release of EV by IHD-J
and WR strains is largely due to a single amino acid difference
in the A34 glycoprotein component of the EV wrapper (Blasco
et al., 1993). Because the A34 proteins of other orthopox-
viruses resemble WR rather than IHD-J, it seems likely that the
mutation arose during tissue culture passage of the latter virus.
Nevertheless, nearly all investigations on EV entry have been
carried out with EVs isolated from the medium of cells infected
with the IHD-J strain of VACV. Mutations of other EV
membrane proteins can also enhance release of EV into the
medium (Katz et al., 2003).
Entry of the MV
Enveloped viruses typically enter cells by fusion of their
surface membrane with either the plasma membrane or the
membrane of an endocytic vesicle (Earp et al., 2005;
Sieczkarski and Whittaker, 2005). Following VACV infection,
MVs have been seen in vesicles (Dales, 1963) and fusing with
the plasma membrane (Armstrong et al., 1973; Carter et al.,
2005; Chang and Metz, 1976). The inhibition of MV entry by
fluoride and cytochalasin B supports an internalization
mechanism (Dales and Kajioka, 1964; Payne and Norrby,
1978) perhaps involving macropinocytosis (Sieczkarski and
Whittaker, 2002). However, endosomal entry usually involves
a low pH step that is inhibited by lysosomotropic drugs, but
such inhibition was not observed for infection by MVs
(Chillakuru et al., 1991; Janeczko et al., 1987; Vanderplasschen
et al., 1998). Furthermore, low pH did not enhance the fusion
of MVs with HeLa cell membranes as determined by lipid
mixing (Doms et al., 1990). Studies of the effect of low pH on
acceleration of MV entry, however, produced mixed results
(Ichihashi, 1996; Vanderplasschen et al., 1998). It is possible
that both plasma membrane and endosomal entry paths are
used depending on the virus strain and cell type. Precedence for
a dual entry pathway exists with herpesviruses (Spear and
Longnecker, 2003).
Fusion mechanisms of MV entry are inconsistent with the
MV double membrane hypothesis because the remaining lipid
bilayer would still surround the core. Images of MVs with
disrupted membranes near the cell surface have led to the
suggestion that fusion is not needed for free cores to enter the
cytoplasm though putative pores in the plasma membrane
(Locker et al., 2000; Sodeik and Krijnse-Locker, 2002). In
view of both indirect and direct data supporting a fusion model,
additional evidence would be needed to seriously consider such
an alternative entry mechanism.
MV attachment and entry proteins
Entry of enveloped viruses typically involves at least three
steps: virus attachment, fusion protein activation, and mem-
brane fusion. There is evidence that certain MV membrane
proteins bind to cell surface glycosaminoglycans and thereby
facilitate virion attachment. D8 has been reported to bind tochondroitin sulfate (Hsiao et al., 1999) and the A27 and H3
proteins to heparan sulfate (Chung et al., 1998; Hsiao et al.,
1998; Lin et al., 2000; Vazquez and Esteban, 1999). But, at
least individually, these proteins are not essential, and the
inhibitory effect of heparin on virus entry appears to be
incomplete and cell-type-dependent (Carter et al., 2005).
Esteban and co-workers called the A27 (P14) protein the
fusion protein because of the ability of specific antibodies and
soluble A27 to block MV entry and cell–cell fusion (Gong et
al., 1990; Hsiao et al., 1998; Rodriguez et al., 1985, 1987;
Vazquez and Esteban, 1999). The A27 protein forms a triple
coiled-coil structure and interacts with the A17 virus membrane
protein through a C-terminal alpha helix. The crucial test
regarding the role of A27, however, requires analysis of a null
mutant. When this experiment was done, the A27 deletion
mutant was found to enter cells and induce syncytia (Senkevich
and Moss, 2005), demonstrating that it is not required for
fusion. In fact, the major defect of A27 null mutants is a failure
of MV wrapping and consequent effects on virus egress
(Rodriguez and Smith, 1990; Ward, 2005). Therefore, the virus
neutralizing activity of antibodies to A27 might be due to steric
effects produced by their binding to MVs. A role for the L1
membrane protein in penetration was suggested by the ability
of a monoclonal antibody to inhibit MVentry after cell binding
(Ichihashi et al., 1994; Wolffe et al., 1995). However, because
conditional lethal L1 null mutants exhibit an assembly block
(Wolffe et al., 1995), it has not been possible to produce MVs
lacking the L1 protein to determine if it has a direct role in
entry as well as assembly.
Recently, a group of previously uncharacterized VACV
proteins (A21, A28, H2, and L5) was shown to have roles in
MV entry (Senkevich et al., 2004a, 2004b; Townsley et al.,
2005a, 2005b). Common features of these proteins, which are
conserved in all sequenced poxviruses, include an N-terminal
or near N-terminal hydrophobic domain and invariant
cysteines. The proteins are expressed late in infection, contain
intramolecular disulfide bonds that are formed by the poxvirus-
encoded cytoplasmic redox system (Senkevich et al., 2002),
and are surface components of the MV membrane. Studies with
inducible mutants indicated that each of the above proteins is
essential and that their null phenotypes are indistinguishable. In
the absence of any one of the four proteins, normal-looking but
non-infectious MVs are produced. In each case, addition of the
mutant MV to cells results in their attachment, but the cores fail
to penetrate into the cytoplasm, indicating a membrane-fusion
block. The requirement for each protein for VACV entry as
well as their conservation in all poxviruses indicates that they
have non-redundant essential functions. The proteins are
associated with each other and additional MV membrane
proteins (Senkevich and Moss, 2005; Senkevich, unpublished
data), suggesting that they function as an entry/fusion complex.
Entry of EV
The key question regarding EVentry concerns the fate of the
wrapper. Fusion of the EV wrapper with the cell membrane
seems most unlikely on general principles because it would
Fig. 2. Steps in formation of syncytia. (1) Progeny EV are displayed on the
surface of the plasma membrane. (2) The EV membrane is disrupted exposing
the MV membrane. (3) The MV membrane fuses with the plasma membrane.
(4) The plasma membrane, now containing embedded viral entry/fusion
proteins, fuses with the plasma membrane of an adjacent cell. In the case of
HA or SPI-3 mutants, syncytia form spontaneously. In fusion from within, low
pH triggers disruption of the CEV membrane and synchronizes fusion of MV
with the plasma membrane. In fusion from without, purified MVs induce low
pH-triggered fusion so that the process starts after step 2. For visual simplicity,
cell – cell fusion is depicted as being induced by a single virion, but actually
many virions are required to form syncytia.
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the finding that the MVentry proteins are required for spread of
VACV infection by EV necessitates the removal of the wrapper
before fusion can occur (Senkevich et al., 2004a, 2004b;
Townsley et al., 2005a, 2005b). The EV membrane is fragile,
and progeny particles with disrupted wrappers are commonly
seen on the surface of infected cells (M. Husain and B. Moss,
unpublished). Furthermore, electron microscopic images of
MVs fusing with the plasma membrane beneath a disrupted
EV wrapper have been obtained (M. Hollinshead and G.L.
Smith, personal communication; J. Heuser, personal communi-
cation). Disruption of the EV wrapper within endosomes has
also been suggested (Ichihashi, 1996; Vanderplasschen et al.,
1998). It should be recognized that investigations of EV entry
have used particles isolated from the medium of cells infected
with the IHD-J strain of VACV and that there are no studies of
how cell-associated EV enter adjacent cells.
Cell surface receptors
Virus entry is generally facilitated by interaction of viral
proteins with specific cell surface proteins or polysaccharides,
which can determine tropism (Sieczkarski and Whittaker,
2005). Receptors can enhance attachment, induce signaling,
and activate metastable viral fusion proteins. Although no
specific receptors have been identified for any poxvirus, the
following information has been obtained. Depletion of plasma
membrane cholesterol inhibits entry of MVs, suggesting a role
of lipid rafts (Chung et al., 2005). VACV MVs and EVs attach
to cells differently (Vanderplasschen and Smith, 1997). In
addition, MVs but not EVs trigger cell signaling events, and
entry of the former requires actin dynamics and tyrosine and
protein kinase C phosphorylation (Locker et al., 2000). A
monoclonal antibody that prevents attachment of VACV MVs
was isolated (Chang et al., 1995), but the target has not yet
been shown to be a specific receptor. The receptors for many
other viruses have been identified by complementation of non-
permissive cells. However, VACV can infect a wide variety of
cultured cells, and replication blocks usually occur at a post-
entry stage. An exception may be resting primary human T
lymphocytes, where there appears to be a block in virus
binding that is reversed by activation (Chahroudi et al., 2005).
VACV-induced syncytia
Cell–cell fusion is unnoticeable during a normal VACV
infection of cultured cells but occurs spontaneously with
certain mutants and can be triggered by briefly lowering the
pH of the medium below 6. Though the phenomenon is
artificial, it can provide important insights for virus entry.
Syncytia form at neutral pH when infected with mutants
containing a disruption of either the A56R (Ichihashi and
Dales, 1971) or K2L (Law and Smith, 1992; Turner and
Moyer, 1992; Zhou et al., 1992) open reading frame encoding
the hemagglutinin (HA) and serine protease inhibitor 3 (SPI-3),
respectively. The HA is a transmembrane protein that is present
on the plasma membrane of infected cells and the EV wrapperbut was not detected in the MV membrane (Payne, 1979). The
SPI-3 gene co-localizes with HA, even though it does not have
a transmembrane segment of its own (Brum et al., 2003). As
SPI-3 has a signal sequence, it probably associates with HA as
it transits the secretory pathway. Fusion occurs late after
infection with HA or SPI-3 mutants and is mediated by
progeny virions on the cell surface. The requirement for
progeny virions is due to the mechanism of poxvirus
morphogenesis. The MV membrane forms within the cyto-
plasm, and the constituent proteins do not traffic to the plasma
membrane through the secretory pathway as with many other
viruses. Antibodies to MV membrane proteins block fusion
(Ichihashi et al., 1994; Turner and Moyer, 1992), suggesting
that the EV wrapper is disrupted prior to syncytia formation.
Moreover, HA-induced fusion is dependent on expression of
the A28 MV entry protein (T. Wagenaar, personal communi-
cation) and presumably the other members of the entry protein
complex. Thus, HA and SPI-3 negatively regulate the normal
entry process, perhaps to prevent re-infection of cells with
progeny virions.
Taken together, the above data suggest that cell–cell fusion
occurs as outlined in Fig. 2: (1) progeny EV collect on the
plasma membrane; (2) the EV wrapper is disrupted to expose
the MV membrane; (3) the MV membrane fuses with the
B. Moss / Virology 344 (2006) 48–5452plasma membrane resulting in the insertion of the viral entry/
fusion complex; (4) the plasma membrane containing the viral
entry/fusion complex fuses with the plasma membrane of an
adjacent cell to form a syncytium. Although, for visual
simplicity, a single virion is shown to induce cell–cell fusion
in Fig. 2, it is likely that this only occurs after many MV fuse
with the cell membrane and large amounts of viral proteins are
inserted into the membrane. Parenthetically, it would be
difficult to provide a mechanism for cell–cell fusion if the
MV membrane was discarded outside of the cell during entry
as has been proposed (Locker et al., 2000; Sodeik and Krijnse-
Locker, 2002). Moreover, if poxviruses do not employ fusion
for entry, the fusion apparatus would have evolved solely to
form syncytia—a most unlikely situation.
The mechanism of HA/SPI-3 inhibition of fusion remains to
be elucidated, but it does not depend on serine protease
inhibitor activity of SPI-3 (Turner and Moyer, 1995). Theoret-
ically, the inhibition could occur at several different stages
including wrapper disruption or MV fusion. Ichihashi and
colleagues (Ichihashi and Oie, 1980; Ichihashi and Oie, 1982;
Oie et al., 1990) suggested that HA inhibits MV infectivity and
that protease treatment activates MVs by digesting traces of
bound HA. One interesting hypothesis is that HA or SPI-3
inhibits fusion by interacting with MV entry/fusion proteins.
Brief low pH treatment of cells at late times after infection
with wild type VACV (expressing both HA and SPI-3) also
results in the formation of syncytia (Doms et al., 1990; Gong et
al., 1990). Although referred to as fusion from within, syncytia
formation is dependent on the presence of progeny virions on
the cell surface (Blasco and Moss, 1991) just as with HA and
SPI-3 mutants. Fusion can also be induced by adding large
numbers of MV to cells and briefly lowering the pH, a
phenomenon called fusion from without (Gong et al., 1990).
Both types of low pH-triggered cell–cell fusion are dependent
on the entry/fusion proteins A21, A28, H2, and L5 (Senkevich
et al., 2004b; Townsley et al., 2005a, 2005b). Therefore, low
pH triggered syncytia formation may follow the same scheme
outlined in Fig. 2, except for low pH treatment and omission of
the EV wrapper disruption step for fusion from without. Low
pH has at least two effects: it disrupts the EV wrapper
(Vanderplasschen et al., 1998) and synchronizes the fusion of
MVs with the plasma membrane (J. Heuser, personal commu-
nication), consistent with accelerated MV entry (Ichihashi,
1996). Although MV entry occurs at neutral pH, presumably,
the amount of viral protein present on the plasma membrane at
any one time is insufficient for cell–cell fusion to occur.
Although the triggering of fusion at the plasma membrane by
lowering the pH of the medium is clearly artificial, it suggests
that endosomes are a natural route of VACV infection at least in
some cells since the pH occurring in these organelles is similar
to that needed to trigger syncytia formation.
Summary and future directions
Taken together, most of the published data are consistent
with the following: (1) the surface of the MV is comprised of a
single lipid membrane embedded with non-glycosylated viralproteins; (2) the MV membrane fuses with the cell membrane
during virus entry, allowing the core to enter the cytoplasm and
initiate gene expression; (3) fusion is mediated by a newly
recognized group of viral protein components of the MV
membrane, which are conserved in all members of the poxvirus
family; (4) the latter MV entry/fusion proteins are required for
cell to cell spread, necessitating the disruption of the membrane
wrapper of extracellular virions prior to fusion; and (5) the
same group of MV entry/fusion proteins is required for virus-
induced cell–cell fusion, which in important ways mimics
virus entry. Additional work is needed to identify other protein
components of the viral entry/fusion complex and especially to
delineate their roles. Given the large numbers of proteins
involved, it seems likely that poxvirus entry/fusion will involve
unique features that distinguish it from the well-characterized
types 1 and 2 fusion mechanisms (Earp et al., 2005). The
discovery of bona fide cell receptors will also be of crucial
importance to the field.
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